Health

#SFHS2608201VNotice Regarding Pricing of Pharmaceutical Specialties

🇫🇷France··Other·Low Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This law sets the prices for a specific pharmaceutical product, LOARGYS, in France. The price details for this injectable solution are noted in an official agreement. This affects healthcare providers and pharmacies that purchase this medicine.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Sets price for LOARGYS at €4,500
  • Applies effective fifteen days after publication
  • Regulates pricing for a specific pharmaceutical product

Obligations

What this law requires

high

Apply the wholesale price (PFHT) of €4,500.00 and retail price including tax (PPTTC) of €4,728.03 for LOARGYS (pegzilarginase) 5mg/ml injectable solution in 0.4ml glass vials

Pharmacies and healthcare providers purchasing LOARGYS
operational
high

Implement the established prices in accordance with the agreement between the economic committee for health products (COMEP) and IMMEDICA PHARMA A.B

Pharmacies, distributors, and healthcare providers selling LOARGYS
operational
medium

Recognize the effective date of this pricing as the fifteenth day following publication in the Journal officiel de la République française

All entities subject to this pricing notice
operational

Affected Parties

Healthcare providersPharmacies

Tags

pharmaceuticals,pricing,healthcare